NONMELANOMA SKIN-CANCER IN THE UNITED-STATES - INCIDENCE
NONMELANOMA SKIN-CANCER IN THE UNITED-STATES - INCIDENCE
复制标题
DOI：
10.1016/s0190-9622(08)81509-5
复制
发表时间：
1994-05-01
影响因子：
13.8
通讯作者：
WEINSTOCK, MA
中科院分区：
文献类型：
--
作者：
MILLER, DL;WEINSTOCK, MA
由于非黑色素瘤皮肤癌的死亡是罕见的，其发病率的量化是特别重要的。虽然其发病率正在迅速增加，但最近的全国估计是16岁。这项研究的目的是估计1994年美国非黑色素瘤皮肤癌的发病率。我们更新了16岁发病率估计值，以反映人口的增长和年龄分布的变化，以及两项基于人群的研究中记录的年龄调整后发病率的增加。1993年美国非黑色素瘤皮肤癌的预计发病率为900，000至1，200，000例，与非皮肤癌的总发病率相似。非黑色素瘤皮肤癌给美国人口带来了巨大的公共卫生负担。确定其发病率并加以预防是重要的优先事项。
Because death from nonmelanoma skin cancer is uncommon, quantification of its morbidity is particularly important. Although its incidence is increasing rapidly, the most recent nationwide estimates are 16 years old. The purpose of this study was to estimate the 1994 nonmelanoma skin cancer incidence in the United States. We updated the 16-year-old incidence estimates to reflect the growth and changing age distribution of the population and the increases in age-adjusted incidence rates documented in two population-based studies. The projected 1993 incidence of nonmelanoma skin cancer in the United States is 900,000 to 1,200,000 cases, similar in magnitude to the overall incidence of noncutaneous cancers. Nonmelanoma skin cancer imposes an enormous public health burden on the U.S. population. Quantification of its morbidity and its prevention are important priorities.